Latuda 60 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FGL7G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,235
Award facts
- Contract value 100% obligated
- $4,235.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,235.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Latuda 60 mg tablets, with an ultimate completion date of December 22, 2025. This non-set-aside contract was awarded competitively and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as one of the nation's largest pharmaceutical distributors.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical procurement across the Department of Defense healthcare system. The IDC enables AmerisourceBergen to provide a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. Latuda (lurasidone), an atypical antipsychotic used in treating schizophrenia and bipolar depression, represents one of the specialized therapeutic medications within the company's extensive federal medical supply portfolio.
Quick answers
Who was awarded contract SPE2DR26FGL7G?
SPE2DR26FGL7G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FGL7G worth?
The government has obligated $4,235 on SPE2DR26FGL7G.
Is contract SPE2DR26FGL7G an order under another contract?
Yes. SPE2DR26FGL7G is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGL7G competed?
The extent of competition for SPE2DR26FGL7G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award